Randolph Abutin

Randolph Abutin is an accomplished toxicologist currently serving as Associate Director of Nonclinical Safety Evaluation at Alkermes since June 2022. In this role, Randolph designs and implements nonclinical safety assessment strategies for a variety of drug candidates, providing accountability for strategic and regulatory aspects within project teams. Prior experience includes holding the position of Senior Scientist at Rubius Therapeutics, where Randolph supported preclinical safety and managed CROs, and serving as Scientist II at CBSET, directing projects in a GLP environment. Additionally, Randolph worked as a Research Scientist at Charles River Laboratories, directing nonclinical studies, and gained foundational experience as a Study Technician and Chemist in earlier roles. Randolph holds a Ph.D. in Pharmacology and Toxicology from Virginia Commonwealth University and a B.S. in Biochemistry from Virginia Tech.